Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.
3.

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ, Esler MD, Dixon JB, Chopra R, Tilbrook AJ, Schlaich MP, Lambert GW.

Diabetes. 2012 Oct;61(10):2506-16. Epub 2012 Jun 4.

4.

Predictors of insulin resistance in the obese with metabolic syndrome.

Manu P, Tsang J, Napolitano BA, Lesser ML, Correll CU.

Eur J Intern Med. 2010 Oct;21(5):409-13. doi: 10.1016/j.ejim.2010.05.015. Epub 2010 Jul 1.

PMID:
20816595
5.

Insulin resistance and the endothelium.

Quiñones MJ, Nicholas SB, Lyon CJ.

Curr Diab Rep. 2005 Aug;5(4):246-53. Review.

PMID:
16033673
6.

The relationship between testosterone and metabolic syndrome.

Kawano H.

Hypertens Res. 2010 Jun;33(6):537-8. doi: 10.1038/hr.2010.52. Epub 2010 Apr 23. No abstract available.

PMID:
20414248
7.

[Comparison of different definitions on metabolic syndrome in obese children].

Fang QY, Wan YP, Wang JL, Shen WR, Chen ZQ, Zhao M.

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Dec;30(12):1297-301. Chinese.

PMID:
20193319
8.

STAMPing out Inflammation.

Waki H, Tontonoz P.

Cell. 2007 May 4;129(3):451-2.

9.

Phospholipid transfer protein in diabetes, metabolic syndrome and obesity.

Qin S, Song G, Yu Y.

Cardiovasc Hematol Disord Drug Targets. 2014;14(2):149-53. Review.

PMID:
25107452
10.

Inflammation and metabolic disorders.

Hotamisligil GS.

Nature. 2006 Dec 14;444(7121):860-7. Review.

PMID:
17167474
11.

Pathogenesis of the metabolic syndrome: insights from monogenic disorders.

Murphy R, Carroll RW, Krebs JD.

Mediators Inflamm. 2013;2013:920214. doi: 10.1155/2013/920214. Epub 2013 May 21. Review.

12.

[Obesity--insulin resistance--type 2 diabetes mellitus].

Małecki MT.

Kardiol Pol. 2006 Oct;64(10 Suppl 6):S561-6. Review. Polish.

PMID:
20527377
13.

Adiponectin and adiponectin receptors in obesity-linked insulin resistance.

Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K.

Novartis Found Symp. 2007;286:164-76; discussion 176-82, 200-3.

PMID:
18269182
14.

[Sleep and metabolic disorders].

Micić DD, Šumarac-Dumanović M, Šušić V, Pejković D, Polovina S.

Glas Srp Akad Nauka Med. 2011;(51):5-25. Review. Serbian.

PMID:
22165724
15.

Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort.

Bo S, Musso G, Gambino R, Villois P, Gentile L, Durazzo M, Cavallo-Perin P, Cassader M.

Am J Clin Nutr. 2012 Nov;96(5):962-9. doi: 10.3945/ajcn.112.040006. Epub 2012 Oct 3.

16.

A brief history of insulin resistance: from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways.

Aronis KN, Mantzoros CS.

Metabolism. 2012 Apr;61(4):445-9. doi: 10.1016/j.metabol.2012.01.001. Epub 2012 Feb 2. No abstract available.

PMID:
22304840
17.

Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese.

Lee ZS, Critchley JA, Tomlinson B, Young RP, Thomas GN, Cockram CS, Chan TY, Chan JC.

Metabolism. 2001 Feb;50(2):135-43.

PMID:
11229419
18.

Insulin resistance: a genetic approach. Overview.

Martínez Larrad MT, González Sánchez JL, Serrano Ríos M.

Nestle Nutr Workshop Ser Clin Perform Programme. 2002;6:79-93; discussion 93-5. Review. No abstract available.

PMID:
16969968
19.

Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus.

Volpe SL.

Crit Rev Food Sci Nutr. 2008 Mar;48(3):293-300. doi: 10.1080/10408390701326235. Review.

PMID:
18274977
20.

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB.

N Engl J Med. 2006 Jun 15;354(24):2552-63.

Supplemental Content

Support Center